Seminars in Pediatric Neurology
Volume 17, Issue 2 , Pages 105-108 , June 2010

Evaluation and Management of Children and Adolescents Presenting with an Acute Setting

  • Marielle A. Kabbouche, MD

      Affiliations

    • Cincinnati Children's Hospital, Cincinnati, OH
    • Corresponding Author InformationAddress reprint requests to Marielle A. Kabbouche, MD, Cincinnati Children's Hospital Medical Center, Headache Center MCL, 2015 3333 Burnett Avenue, Cincinnati, OH 45229
    • ,
  • Catalina Cleves, MD

      Affiliations

    • Cleveland Clinic, Cleveland, OH

References 

  1. Lewis DW, Qureshi F. Acute headache in children and adolescents presenting to the emergency department. Headache. 2000;40:200–203
  2. Kan L, Nagelberg J, Maytal J. Headaches in a pediatric emergency department: Etiology, imaging, and treatment. Headache. 2000;40:25–29
  3. Burton LJ, Quinn B, Pratt-Cheney JL, et al. Headache etiology in a pediatric emergency room. Pediatr Emerg Care. 1997;13:1–4
  4. Linder S. Comprehensive pediatric headache examination. Pediatr Ann. 2005;5:442–446
  5. Evans RW. Diagnostic testing for headache. Med Clin North Am. 2001;85:865–885
  6. Medina SL, Pinter JD, Zurakowski , et al. Children with headache: Clinical predictors of surgical space occupying lesions and the role of neuroimaging. Pediatr Radiol. 1997;202:819–824
  7. Lewis DW, Ashwal S, Dahl G, et al. Practice parameter: Evaluation of children and adolescents with recurrent headaches: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002;59:490–498
  8. Blumenthal HJ, Weisz MA, Kelly KM, et al. Treatment of primary headache in the emergency department. Headache. 2003;43:1026–1031
  9. Coppola M, Yealy DM, Leibold RA. Randomized placebo-controlled evaluation of prochlorperazine vs metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26:541–546
  10. Kabbouche MA, Vockell Al Le, Cates SL, et al. Powers, S W (Tolerability and effectiveness of prochlorperazine for intractable migraine). Pediatrics. 2001;107:E62
  11. Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci. 1987;7:4129–4136
  12. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28:183–187
  13. Larkin G. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med. 1999;6:668–670
  14. Brousseau DC, Duffy SJ, Anderson AC, et al. Treatment of pediatric migraine headaches: A randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004;43:256–262
  15. Freitag FG, Collins SD, Carlson HA, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis (Depakote ER Migraine Study Group). Neurology. 2002;58:1652–1659
  16. Linder SL. Subcutaneous sumatriptan in the clinical setting: The first fifty consecutive patients with acute migraine in a pediatric neurology office practice. Headache. 1996;36:419–422
  17. Kabbouche MA, Powers SW, Segers A, et al. Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache. 2009;49:106–109
  18. Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001;41:976–980
  19. Linder SL. Treatment of childhood headache with dihydroergotamine mesylate. Headache. 1994;34:578–580

PII: S1071-9091(10)00033-1

doi: 10.1016/j.spen.2010.04.004

Seminars in Pediatric Neurology
Volume 17, Issue 2 , Pages 105-108 , June 2010

Article Tools